- Home
- OXLC vs INMD Comparison
OXLC vs INMD Comparison
Compare OXLC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXLC
- INMD
- Stock Information
- Founded
- OXLC 2010
- INMD 2008
- Country
- OXLC United States
- INMD Israel
- Employees
- OXLC N/A
- INMD N/A
- Industry
- OXLC Investment Managers
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OXLC Finance
- INMD Health Care
- Exchange
- OXLC Nasdaq
- INMD Nasdaq
- Market Cap
- OXLC 1.7B
- INMD 1.4B
- IPO Year
- OXLC N/A
- INMD 2019
- Fundamental
- Price
- OXLC $5.22
- INMD $18.24
- Analyst Decision
- OXLC Strong Buy
- INMD Buy
- Analyst Count
- OXLC 1
- INMD 6
- Target Price
- OXLC $6.00
- INMD $22.60
- AVG Volume (30 Days)
- OXLC 1.9M
- INMD 1.1M
- Earning Date
- OXLC 11-01-2023
- INMD 10-30-2024
- Dividend Yield
- OXLC 18.86%
- INMD N/A
- EPS Growth
- OXLC N/A
- INMD N/A
- EPS
- OXLC 1.20
- INMD 1.84
- Revenue
- OXLC $130,145,365.00
- INMD $423,746,000.00
- Revenue This Year
- OXLC $136.15
- INMD N/A
- Revenue Next Year
- OXLC $5.51
- INMD $3.13
- P/E Ratio
- OXLC $4.24
- INMD $9.93
- Revenue Growth
- OXLC N/A
- INMD N/A
- 52 Week Low
- OXLC $4.41
- INMD $14.87
- 52 Week High
- OXLC $5.70
- INMD $26.80
- Technical
- Relative Strength Index (RSI)
- OXLC 42.03
- INMD 52.47
- Support Level
- OXLC $5.33
- INMD $17.11
- Resistance Level
- OXLC $5.42
- INMD $19.85
- Average True Range (ATR)
- OXLC 0.06
- INMD 0.63
- MACD
- OXLC -0.01
- INMD -0.15
- Stochastic Oscillator
- OXLC 3.57
- INMD 45.05
About OXLC Oxford Lane Capital Corp.
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.